Home › Funds › Millennium Management › LCTX
Millennium Management position in LCTX
LINEAGE CELL THERAPEUTICS IN · Health Care
Latest position (Q2 2026)3.02M sh
Reported value held$3.95M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 19.43K | $49.00K | New |
| Q4 2021 | 333.22K | $816.00K | Add |
| Q1 2022 | 178.49K | $275.00K | Reduce |
| Q2 2022 | 1.02M | $1.61M | Add |
| Q3 2022 | 506.31K | $572.00K | Reduce |
| Q4 2022 | 399.04K | $467 | Reduce |
| Q1 2023 | 1.40M | $2.10K | Add |
| Q4 2023 | 58.00K | $63.22K | New |
| Q1 2024 | 41.70K | $61.71K | Reduce |
| Q2 2024 | 168.98K | $168.52K | Add |
| Q2 2025 | 2.60M | $2.36M | New |
| Q3 2025 | 2.68M | $4.53M | Add |
| Q4 2025 | 2.11M | $3.52M | Reduce |
| Q1 2026 | 5.56M | $8.79M | Add |
| Q2 2026 | 3.02M | $3.95M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LCTX
- BlackRock Inc 13.19M sh · $17.27M · Q2 2026
- Vanguard Group 9.64M sh · $16.11M · Q4 2025
- Geode Capital Management 5.30M sh · $6.94M · Q2 2026
- Northern Trust Corp 1.66M sh · $2.17M · Q2 2026
- Morgan Stanley 1.47M sh · $1.93M · Q2 2026
- Renaissance Technologies 1.34M sh · $1.76M · Q2 2026
- Marshall Wace 1.28M sh · $1.68M · Q2 2026
- UBS Group AG 687.05K sh · $900.04K · Q2 2026
- Charles Schwab Investment Management 577.43K sh · $756.44K · Q2 2026
- Citadel Advisors 465.57K sh · $609.90K · Q2 2026
- Goldman Sachs Group 433.27K sh · $567.58K · Q2 2026